Rachel Mears

Rachel Mears

Director/Board Member at Neogene Therapeutics, Inc.

Health Technology
Consumer Services
Finance

Profile

Rachel Mears is currently the Director at Neogene Therapeutics, Inc. and also holds the position of Director at Human Immunology Biosciences, Inc. She is also an Investor at Jeito Capital SASU.
Previously, she worked as a Director at HIBio, Inc. Ms. Mears completed her undergraduate degree at Stanford University and her graduate degree at New York University School of Law.

Rachel Mears active positions

CompaniesPositionStart
Director/Board Member 05/10/2020
Private Equity Investor 30/11/2019
Director/Board Member -
All active positions of Rachel Mears

Former positions of Rachel Mears

CompaniesPositionEnd
Director/Board Member -
See the detail of Rachel Mears's experience

Training of Rachel Mears

New York University School of Law Graduate Degree
Stanford University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rachel Mears's experience

Connections

24

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies4

Health Technology

Finance

Health Technology

Health Technology

See company connections